Stiftung Warentest publishes book "Medication in Test - Cancer"
The new book "Medicines in the Test - Cancer" from Stiftung Warentest will be available tomorrow. On 272 pages, the Foundation provides independent and differentiated information about the advantages and disadvantages of the various medicines used in cancer therapy. For example, cancer patients should be given an independent assessment of the drug treatment options.
The book answers typical questions from cancer patients such as "Which therapy is the right one?", "Which side effects occur?" Or "How much does the quality of life suffer?" In the run-up to drug therapy, those affected and their families can inform themselves independently and objectively, according to the Stiftung Warentest report.
Answers to the most pressing questions of cancer patients In the new book by Stiftung Warentest, cancer patients and other interested parties will find answers to the most pressing questions that arise in the context of drug cancer therapy. "For this, the most important drugs used in cancer therapy are discussed: what opportunities they offer, what side effects can occur and how the study situation is to be assessed," according to the Stiftung Warentest report. All drugs would be discussed objectively based on the latest scientific research. The experience of clinically active oncologists was also incorporated here. According to its own statements, the "Stiftung Warentest brings transparency to the current study situation and explains in an understandable and precise manner what the patients have to watch out for."
Orientation aid for cancer patients The Stiftung Warentest sees its new book as "orientation aid so that patients can make their own decisions" and can find a suitable therapy together with the treating doctor. However, such a book can hardly be more of a rough guide, since an appropriate evaluation of existing therapy options should always be carried out by a specialist. However, with the help of the book "Medications in the Test - Cancer" one or the other doctor may also gain interesting insights into certain medicines. (fp)
Cancer drug stops Alzheimer's
Pharmaceutical company withdraws cancer drug
Nanoparticles for cancer therapy
Image: Sara Hegewald / pixelio.de